首页> 外文期刊>Transplantation: Official Journal of the Transplantation Society >Renal function recovery in children undergoing combined liver kidney transplants.
【24h】

Renal function recovery in children undergoing combined liver kidney transplants.

机译:接受联合肝肾移植的儿童的肾功能恢复。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

BACKGROUND AND METHOD: Combined liver kidney transplant (CLKT) is a recognized treatment option for end-stage renal disease due to primary hyperoxaluria (PH-I) and cystic disorders, yet there is only limited data on posttransplant renal function recovery. The objective of this study was to assess postoperative renal function of children with PH-I (group A) undergoing CLKT and to compare this with a cohort of children (group B) who received CLKT for other indications. RESULTS: Twenty-three patients underwent CLKT between 1994 and 2008 (group A: 9 patients; median age 8.6 [1.6-16.7] years; group B: 14 patients; median age 8.5 [1.9-14.6] years). The median follow-up was 88 (14-112) and 22 (4-109) months. Both groups were transplanted with comparable organs. Eight (8/9) and six (6/14) patients received preoperative renal support in each group, respectively, whereas an equal proportion of them required early postoperative renal support (4/8; 50% and 3/6; 50%, respectively). Glomerular function was significantly different between groups until first year posttransplant (median estimated glomerular filtration rate: groups A vs. B; at pretransplant, 3 mo, 6 mo, and 12 mo posttransplant, respectively; 11.06 vs. 12.61 [P=0.4], 40.78 vs. 75.83 [P=0.03], 42.59 vs. 80.56 [P=0.04] and 53.57 vs. 76.75 [P=0.005]). Overall 1-year survival is 89% versus 90% and 5-year survival is 89% versus 62%, respectively. SUMMARY: Children with PH-I receiving CLKT seem to have delayed recovery of renal function compared with polycystic disease, possibly due to mobilization of systemic oxalate. Consideration should be given to earlier or preemptive transplantation for children with PH-I.
机译:背景与方法:联合肝肾移植(CLKT)是公认的治疗原发性高草酸尿症(PH-1)和囊性疾病的终末期肾脏疾病的治疗选择,但关于移植后肾功能恢复的数据有限。这项研究的目的是评估接受CLKT治疗的PH-1儿童(A组)的术后肾功能,并将其与接受CLKT治疗的其他适应症儿童(B组)进行比较。结果:1994年至2008年间,有23例患者接受了CLKT治疗(A组:9名患者;中位年龄8.6 [1.6-16.7]岁; B组:14名患者;中位年龄8.5 [1.9-14.6]岁)。中位随访时间为88(14-112)和22(4-109)个月。两组均移植了可比较的器官。每组分别有八(8/9)和六(6/14)例患者接受术前肾支持,而同样比例的患者需要术后早期肾支持(4/8; 50%和3/6; 50%,分别)。直到移植后第一年,各组之间的肾小球功能显着不同(中值估计的肾小球滤过率:A组与B组;移植前分别为移植后3 mo,6 mo和12 mo; 11.06 vs. 12.61 [P = 0.4], 40.78 vs. 75.83 [P = 0.03],42.59 vs. 80.56 [P = 0.04]和53.57 vs. 76.75 [P = 0.005])。总体1年生存率分别为89%和90%和5年生存率分别为89%和62%。摘要:与多囊性疾病相比,接受CLKT治疗的PH-1儿童似乎延迟了肾功能的恢复,这可能是由于系统性草酸盐的动员所致。对于PH-1的儿童,应考虑尽早或抢先移植。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号